Brownstein and his team noted that women and adults aged 66 to 75 saw the largest decreases in obesity. People living in the ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage ...

Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency ...

More than one in four UK adults are obese, but only a small number will be eligible for the latest treatment from the NHS ...

Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...

Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr.

Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used ...

Dr. Mehmet Oz has been nominated by President-elect Donald Trump to lead the federal Centers for Medicare & Medicaid Services ...

A preliminary study on popular weight loss drugs finds participants shed more weight on Zepbound than on Novo Nordisk’s ...

Americans are falling farther behind the rest of the developed world when it comes to health and life expectancy, a new study ...

The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.